BDX
BECTON DICKINSON & CO
BECTON DICKINSON & CO (BDX) has 12 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 28, 2026.
The most active filer is EVP, Chief Revenue Officer Feld Michael with 5 filings. Insiders have net sold $789K over the trailing 6 months.
- Industry:Medical - Instruments & Supplies
- CEO:Thomas E. Polen Jr.
- Employees:70,000
- HQ:Franklin Lakes, NJ, US
- IPO:1973-02-21
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$789K
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$45.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| EVP, Chief Revenue Officer | Sale | 75 | $12K | Jul 28 | SEC ↗ | |
| EVP, Chief Revenue Officer | Sale | 75 | $11K | Jun 27 | SEC ↗ | |
| EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $160K | Jun 25 | SEC ↗ | |
Garrison Michael DavidFirst filing | EVP & Pres Med.Essntl&BioPharm | Sale | 1,100 | $167K | Jun 11 | SEC ↗ |
Polen Thomas E JrFirst filing | Chairman, CEO and President | Sale | 2,764 | $405K | Jun 3 | SEC ↗ |
| EVP, Chief Revenue Officer | Sale | 75 | $11K | May 27 | SEC ↗ | |
| EVP, Chief Revenue Officer | Sale | 74 | $11K | Apr 28 | SEC ↗ | |
Feld MichaelFirst filing | EVP, Chief Revenue Officer | Sale | 75 | $12K | Mar 27 | SEC ↗ |
Congress trading BDX
See timeline →- RRep. Thomas H. KeanSale$1,001 - $15,0002026-05-21
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
BECTON DICKINSON & CO is in the Healthcare sector.